Veeda Clinical Research Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price
Not Listed

Veeda Clinical Research Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Hospital & Healthcare Services | Small Cap

DeciZen - make an informed investing decision on Veeda Clinical Research

Based on:

DeciZen not available for IPO

10 Year X-Ray of Veeda Clinical Research:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 21.3%26.1%57.7%78.1%5.9%60.5%8.9%8.5%1.5%-1%-
Value Creation
Index
0.50.93.14.6-0.63.3-0.4-0.4NANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 97131182218151196224296275262196
Sales YoY Gr.-34.9%39.4%19.7%-30.8%29.4%14.4%32.3%-7%-4.7%-
Adj EPS 1.739.314.70.110.53.24.40.6-1.713.7
YoY Gr.-78.2%207.6%57.6%-99.5%12987.5%-69.2%35.3%-86.5%-389.8%-
BVPS (₹) 8.211.320.715.41537.189.194141.2151.452
Adj Net
Profit
5.61030.651.80.337.817.123.13.7-11.363
Cash Flow from Ops. 14.6724.975.29.176.612.775.120.514.1-
Debt/CF from Ops. 0.92.90.60.11.80.30000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 11.7%11.7%5.4%-4.7%
Adj EPS -200.1%-284.5%-180.9%-389.8%
BVPS38.2%58.8%19.3%7.2%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
13.620.344.159.30.329.35.34.70.5-1.213.5
Op. Profit
Mgn %
1917.53337.713.834.118.31910.52.5NAN
Net Profit
Mgn %
5.87.616.823.70.219.37.67.81.4-4.332.3
Debt to
Equity
0.30.40.20.10.20.10000-
Working Cap
Days
1361391241101711862382232502630
Cash Conv.
Cycle
483739468056776766660

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Veeda Clinical Research Ltd.

Standalone Consolidated
TTM EPS (₹) 13.7 0
TTM Sales (₹ Cr.) 196 0
BVPS (₹.) 52 2
Reserves (₹ Cr.) 231 -
P/BV 0.00 0.00
PE 0.00 0.00
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 9.3
Face Value (₹) 2
Industry PE 90.5

Management X-Ray of Veeda Clinical Research:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Veeda Clinical Research - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Veeda Clinical Research

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales97.02130.85182.45218.44151.27195.81223.93296.15275.45262.43
Operating Expenses 78.64107.95122.18136.14131.89129.10182.85241.74247.49256.95
Manufacturing Costs28.1138.5145.5047.1547.6549.5480.05115.8599.8091.49
Material Costs10.3513.3015.4714.3313.2913.9518.8317.8123.5824.38
Employee Cost 20.6931.3834.9943.6054.3349.1763.5874.0588.08104.41
Other Costs 19.4824.7626.2231.0516.6216.4320.3934.0236.0236.67
Operating Profit 18.3822.9060.2782.3119.3966.7241.0854.4227.965.48
Operating Profit Margin (%) 18.9%17.5%33.0%37.7%12.8%34.1%18.3%18.4%10.2%2.1%
Other Income 1.435.570.785.342.4138.574.239.1517.5621.84
Interest 1.642.642.702.385.094.814.585.335.875.34
Depreciation 8.8511.2610.589.4415.8014.9515.5321.1335.0237.01
Exceptional Items 0000000000
Profit Before Tax 9.3314.5847.7775.820.9085.5325.2037.104.63-15.04
Tax 3.484.6316.8623.200.9422.256.8711.151.57-3.62
Profit After Tax 5.859.9630.9152.62-0.0463.2918.3325.953.06-11.42
PAT Margin (%) 6.0%7.6%16.9%24.1%-0.0%32.3%8.2%8.8%1.1%-4.4%
Adjusted EPS (₹)1.83.09.47.6-0.017.63.54.90.5-1.7
Dividend Payout Ratio (%)0%0%0%0%0%0%66%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 44.1354.088589.5188169.17471.34497.04889.25995.53
Share Capital 17.5917.5917.5935.8235.8235.8310.5810.5812.6013.16
Reserves 26.5436.5067.4153.6952.18133.34460.77486.46876.65982.37
Minority Interest0000000000
Debt9.6313.76104.8816.6924.320000
Long Term Debt9.4612.99100000000
Short Term Debt0.180.7804.8816.6924.320000
Trade Payables7.539.317.9211.218.7412.3321.4819.1919.5415.55
Others Liabilities 34.6424.4022.7723.5662.6073.5097.09135.88120.77143.35
Total Liabilities 95.93101.56125.68129.17176.04279.31589.91652.111,029.551,154.43

Fixed Assets

Gross Block85.2799.68108.65111.91107118.63115.76170.62263.51275.63
Accumulated Depreciation4354.2564.7274.1629.3444.2846.0764.89101.03126.03
Net Fixed Assets 42.2745.4343.9237.7577.6674.3669.70105.72162.49149.60
CWIP 2.900.310.597.740.511.1310.2186.449.09
Investments 2.800.142.751.77066.87276.86291.17612.56781.11
Inventories4.184.234.984.734.785.666.994.906.096.21
Trade Receivables19.3421.7237.5643.6336.0545.1577.3971.1460.4658.08
Cash Equivalents 1.612.038.1320.1217.5717.8160.6757.7259.5624.96
Others Assets 22.8227.7027.7413.4339.4868.3388.09113.46121.96125.37
Total Assets 95.93101.56125.68129.17176.04279.31589.91652.111,029.551,154.43

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 14.586.9624.8975.239.1376.6312.7375.0620.5214.11
PBT 9.3314.5847.7775.820.9085.5325.2037.104.63-15.04
Adjustment 10.3713.0312.948.2419.6618.3420.9032.4528.7548.08
Changes in Working Capital -0.22-13.67-18.5714.19-2.29-4.22-21.4119.07-9.59-19
Tax Paid -4.90-6.99-17.26-23.03-9.14-23.03-11.96-13.55-3.260.08
Cash Flow From Investing Activity -21.09-8.37-11.96-8.63-9.03-92.58-141.83-106.71-229.144.09
Capex -27.40-11.83-9.38-10.12-9.06-3.95-11.94-46.22-57.15-7.73
Net Investments 00-2.931.76-0.47-65.76-62-45-42.36107.48
Others 6.313.460.34-0.280.50-22.87-67.89-15.48-129.63-95.67
Cash Flow From Financing Activity 3.601.48-6.46-55.57-3.4517.07172.108.15195.88-17.55
Net Proceeds from Shares 0000017.99230.080210.210
Net Proceeds from Borrowing 0000-5.4200000
Interest Paid -1.64-2.66-2.70-2.43-0.98-0.76-4.58-5.24-5.41-5.34
Dividend Paid 000-31.2700-12.08000
Others 5.244.13-3.77-21.882.95-0.16-41.3313.39-8.92-12.21
Net Cash Flow -2.910.066.4611.02-3.351.1143-23.49-12.750.65

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)24.231.0558.8886.1-0.0867.86.065.360.44-1.21
ROCE (%)21.3326.1257.7378.055.8660.478.928.531.49-1.02
Asset Turnover Ratio1.21.331.611.710.990.860.520.480.330.24
PAT to CFO Conversion(x)2.490.70.811.43N/A1.210.692.896.71N/A
Working Capital Days
Receivable Days625759689676100928782
Inventory Days131298111010779
Payable Days183231203244274276328417300263

Veeda Clinical Research Ltd Stock News

Veeda Clinical Research Ltd FAQs

The current trading price of Veeda Clinical Research on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Veeda Clinical Research stood at ₹0.00.
The latest P/E ratio of Veeda Clinical Research as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Veeda Clinical Research as of 31-Dec-1969 is 0.00.
The 52-week high of Veeda Clinical Research is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Veeda Clinical Research is ₹195.8 ( Cr.) .

About Veeda Clinical Research Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×